Hanall Biopharma Q2 Operating Profit 463 Million KRW... Down 69.1% YoY
[Asia Economy Reporter Lee Gwan-joo] HanAll Biopharma announced on the 27th that its operating profit for the second quarter of this year was 463 million KRW, a decrease of 69.1% compared to the same period last year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
During the same period, sales increased by 12.0% to 26.25 billion KRW, and net loss for the period was 684 million KRW, turning to a deficit.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
